No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use
-
Female
-
Humans
-
Immunity, Cellular / drug effects*
-
Lupus Erythematosus, Systemic / drug therapy*
-
Lupus Erythematosus, Systemic / immunology
-
Male
-
Middle Aged
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
pembrolizumab